Rezolute Inc
Change company Symbol lookup
Select an option...
RZLT Rezolute Inc
BAC Bank of America Corp
SDA SunCar Technology Group Inc
RAIN Rain Oncology Inc
EOI Eaton Vance Enhanced Equity Income Fund
OLNCF Omni Lite Industries Canada Inc
RGNX Regenxbio Inc
OGSYS Otis Gallery LLC
RDN Radian Group Inc
SLNO Soleno Therapeutics Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Rezolute, Inc. (Rezolute) is a clinical-stage biopharmaceutical company, which is engaged in developing therapies for metabolic diseases related to chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is an intravenously administered human monoclonal antibody that binds to a unique site (allosteric) on the insulin receptor in insulin target tissues, such as in the liver, fat, and muscle. The antibody modifies insulin’s binding and signaling to maintain glucose levels in a normal range, which counteracts the effects of elevated insulin in the body. It is a potential treatment for congenital hyperinsulinism (HI), which is an ultra-rare pediatric genetic disorder characterized by excessive production of insulin by the pancreas in Phase II. The Company is also developing RZ402, an oral plasma kallikrein inhibitor (PKI) being developed as a potential therapy for the chronic treatment of diabetic macular edema (DME) in Phase I.

Price
Delayed
$2.05
Day's Change
0.075 (3.81%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.05
Day's Low
1.99
Volume
(Light)

Today's volume of 288 shares is on pace to be much lighter than RZLT's 10-day average volume of 13,011 shares.

288
  • Prev Close
    1.97
  • Today's Open
    1.99
  • Day's Range
    1.99-2.05
  • Avg Vol (10-day)
    13.0K
  • Last (time)
    9:41a ET 06/02/23
  • Last (size)
    100
  • 52-Wk Range
    1.34 - 3.59
    LowHigh
  • (06/27/22 - 12/19/22)
    52.60%
  • 81.3%
  • Market Cap
    75.3M
  • Shares Outstanding
    36.8M
  • -1.06
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.2
  • 67.40
  • (% of float 05/15/23)
    0.52

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.